Institute of Clinical Neurosciences, Germany Integrated Center for Research and Treatment of Vertigo, Balance and Ocular Motor Disorders, Ludwig-Maximilian University, Klinikum Grosshadern, Marchioninistr. 15, D-81377 Munich, Germany.
Restor Neurol Neurosci. 2010;28(1):69-82. doi: 10.3233/RNN-2010-0504.
The long-term course and the frequency of relapses for various peripheral vestibular disorders and somatoform phobic postural vertigo are discussed with respect to the clinically most important questions for thus afflicted patients. This review is mainly based on our own long-term follow-up studies and takes into consideration the most relevant literature. The following syndromes are discussed in detail. Vestibular neuritis: the recovery rate of peripheral vestibular function lies between 40-63% depending on early-onset treatment with corticosteroids; the recurrence rate within 10 years is 2%. Menière's disease} loss of auditory and vestibular function occurs mainly in the first 5 to 10 years; frequency of vertigo attacks may decline after 5 to 10 years; bilateral involvement increases with increasing duration of the condition in up to 30-50%; vestibular drop attacks may occur early or late within the course, mostly with spontaneous remission; high-dose and long-term treatment with betahistine significantly reduces attack frequency in Menière's disease, Benign paroxysmal positioning vertigo: the recurrence rate is 50% within 10 years (in females 58%, in males 39%), most recurrences (80%) being observed within the first year after initial relief; recurrence rate in the seventh decade is half of that in the sixth decade. Vestibular paroxysmia: medical treatment with carbamazepine or oxcarbazepine leads to a continuous significant reduction in attack frequency, intensity, and duration of 10-15% of baseline. Bilateral vestibulopathy: recovery of vestibular function is limited to single cases depending on their etiology. Phobic postural vertigo: within 5 to 16 years 27% of the patients are symptom-free, 48% improve, 22% remain unchanged, and 3% worsen; a detailed explanation of the mechanisms that cause and the factors that provoke attacks is imperative, as well as instructions for self-controlled desensitization within the context of behavioral therapy.
各种外周性前庭障碍和躯体形式恐惧症性姿势性眩晕的长期病程和复发频率,根据受影响患者的临床最重要问题进行了讨论。本综述主要基于我们自己的长期随访研究,并考虑了最相关的文献。详细讨论了以下综合征。
前庭神经炎:根据早期使用皮质类固醇治疗,外周前庭功能的恢复率在 40-63%之间;10 年内的复发率为 2%。
梅尼埃病:听力和前庭功能丧失主要发生在最初的 5 到 10 年内;眩晕发作的频率可能在 5 到 10 年后下降;双侧受累随着病情持续时间的增加而增加,最多可达 30-50%;前庭发作可能在病程中早期或晚期发生,大多自行缓解;倍他司汀的高剂量和长期治疗可显著降低梅尼埃病的发作频率。
良性阵发性位置性眩晕:10 年内的复发率为 50%(女性为 58%,男性为 39%),大多数复发(80%)发生在初次缓解后的第一年;第七个十年的复发率是第六个十年的一半。
前庭阵发症:卡马西平或奥卡西平的药物治疗可导致发作频率、强度和持续时间持续显著降低,降幅为基线的 10-15%。
双侧前庭病变:根据其病因,前庭功能的恢复仅限于单个病例。
恐惧症性姿势性眩晕:在 5 到 16 年内,27%的患者无症状,48%的患者改善,22%的患者保持不变,3%的患者恶化;必须详细解释导致发作的机制和引发发作的因素,并在行为治疗的背景下指导自我控制脱敏。